HeFH

NewAmsterdam drug cuts cholesterol, but by less than expectations, in phase 3 test
Fierce Biotech
Mon, 07/29/24 - 10:27 am
NewAmsterdam Pharma
cholesterol
clinical trials
obicetrapib
HeFH
FDA Pauses Verve’s Trial Plan for Gene-Editing Therapy for High Cholesterol
MedCity News
Mon, 11/7/22 - 05:17 pm
Verve Therapeutics
gene editing
FDA
heterozygous familial hypercholesterolemia
VERVE-101
HeFH
Amgen receives FDA approval for Repatha to treat pediatric HeFH patients
Pharmaceutical Business Review
Mon, 09/27/21 - 11:00 am
Amgen
Repatha
FDA
pediatric
HeFH